Short bowel syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:104008
Who is this for?
Show terms as
21Active trials57Specialists8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome

Takeda

TrialRECRUITING
Feb 2026Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Zealand Pharma — PHASE3

TrialRECRUITING
Feb 2026Effect of Parenteral Support on FibroScan in Short Bowel Syndrome

Rigshospitalet, Denmark

TrialNOT YET RECRUITING
Jan 2026Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

Jinling Hospital, China — NA

TrialNOT YET RECRUITING
Dec 2025Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome

Zealand Pharma — PHASE3

TrialENROLLING BY INVITATION
Jun 2025A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

Takeda — PHASE3

TrialRECRUITING
May 2025Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

Napo Therapeutics, S.p.A. — PHASE2

TrialRECRUITING
May 2025Elemental 028 Extra Case Studies

Nutricia UK Ltd — NA

TrialRECRUITING
Mar 2025Irritable Bowel Syndrome Regional Cohort

University Hospital, Rouen — NA

TrialRECRUITING
Mar 2025Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

Lindsey Russell, MD — EARLY_PHASE1

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Short bowel syndrome.

20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

20 recruitingView all trials with filters →
Phase 37 trials
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Phase 3
Actively Recruiting
· Sites: St Louis, Missouri; New York, New York +17 more · Age: 1890 yrs
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
Phase 3
Active
PI: Zealand Pharma (Zealand Pharma) · Sites: Washington D.C., District of Columbia; Rochester, Minnesota +17 more · Age: 1890 yrs
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
Phase 3
Actively Recruiting
PI: Huanlong Qin (Shanghai 10th People's Hospital) · Sites: Beijing, Beijing Municipality; Chongqing, Chongqing Municipality +6 more · Age: 1499 yrs
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
Phase 3
Active
PI: Zealand Pharma (Zealand Pharma) · Sites: Washington D.C., District of Columbia; Chicago, Illinois +25 more · Age: 1890 yrs
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Phase 3
Actively Recruiting
PI: Study Director (Takeda) · Sites: Changping, Beijing Municipality; Dongcheng, Beijing Municipality +2 more · Age: 1899 yrs
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
Phase 3
Active
PI: Tomasz Masior (VectivBio AG) · Sites: Los Angeles, California; Naples, Florida +64 more · Age: 1899 yrs
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Phase 3
Enrolling by Invitation
· Sites: Rochester, Minnesota; Omaha, Nebraska +14 more · Age: 1899 yrs
Phase 22 trials
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Phase 2
Actively Recruiting
· Sites: Boston, Massachusetts; Cleveland, Ohio +11 more · Age: 1899 yrs
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Phase 2
Actively Recruiting
· Sites: Aachen; Berlin +6 more · Age: 1899 yrs
Phase 11 trial
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Phase 1
Actively Recruiting
PI: Niasha MICHOT, MD (CHRU Nancy) · Sites: Vandœuvre-lès-Nancy, Lorraine · Age: 1899 yrs
N/A4 trials
Elemental 028 Extra Case Studies
N/A
Actively Recruiting
PI: Gary Hubbard (Nutricia UK) · Sites: Trowbridge · Age: 399 yrs
Fiber Food Introduction in Pediatric Short Bowel Syndrome
N/A
Active
PI: Lindsey Albenberg, DO (Children's Hospital of Philadelphia) · Sites: Philadelphia, Pennsylvania · Age: 018 yrs
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
N/A
Actively Recruiting
PI: Mark Puder, MD, PhD. (Boston Children's Hospital) · Sites: Boston, Massachusetts · Age: 218 yrs
TED_ORG: Study on Short Bowel Syndrome
N/A
Actively Recruiting
· Sites: Florence, Florence · Age: 017 yrs
Other6 trials
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Enrolling by Invitation
PI: Mark Puder, MD, PhD (Boston Children's Hospital) · Sites: Boston, Massachusetts · Age: 218 yrs
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
Actively Recruiting
PI: Charlotte BERGOIN, Doctor (Service d'hépato-gastro-entérologie et Assistance ) · Sites: Pierre-Bénite · Age: 1899 yrs
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
Actively Recruiting
PI: Study Director (Takeda) · Sites: Guangzhou, Guangdong; Shanghai, Shanghai Municipality +2 more · Age: 117 yrs
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Actively Recruiting
PI: Study Director (Takeda) · Sites: Cambridge, Massachusetts · Age: 1899 yrs
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Actively Recruiting
PI: Study Director (Takeda) · Sites: Tokyo, Tokyo; Tokyo, Tokyo
Registry for Participants With Short Bowel Syndrome
Active
PI: Study Director (Shire) · Sites: Lexington, Massachusetts

Specialists

Showing 25 of 57View all specialists →
LJ
Lissette Jimenez
Specialist
PI on 1 active trial
SM
Sandrine Lemoine, MD
Specialist
PI on 1 active trial
LR
Lindsey Russell
Specialist
PI on 1 active trial
NM
Niasha MICHOT, MD
Specialist
PI on 1 active trial
MP
Mark Puder, MD, PhD
BOSTON, MA
Specialist
PI on 2 active trials
FM
Florian POULLENOT, MD
Specialist
PI on 2 active trials
JP
Julio S Marchini, PhD
Specialist
PI on 1 active trial
NP
Nathalie KAPEL, MPharma PhD
Specialist
PI on 1 active trial
AM
Alain LACHAUX, MD
Specialist
PI on 2 active trials
MM
Meghan A Arnold, MD
Specialist
PI on 2 active trials
GM
Gertrud Koefoed Rasmussen, MSc
Specialist
PI on 1 active trial
AP
alison culkin, PhD
STOUGHTON, MA
Specialist
PI on 1 active trial
QP
Qing Yang, MD, PhD
Specialist
PI on 2 active trials
RH
Ruigang Hou
Specialist
PI on 1 active trial4 Short bowel syndrome publications
MM
Michael Camilleri, MD
ROCHESTER, MN
Specialist
PI on 6 active trials
OP
Olivier Goulet, MD, PhD
Specialist
PI on 2 active trials
CM
Christopher Duggan, MD, MPH
BOSTON, MA
Specialist
PI on 1 active trial
LM
Lynn Malec, MD
MILWAUKEE, WI
Specialist
PI on 1 active trial
AM
Alexandra Carey, MD
Specialist
PI on 1 active trial1 Short bowel syndrome publication
JP
Juan C. Espín, PhD
Specialist
PI on 1 active trial
HD
Hsieh-Hsun Ho, Ph. D.
Specialist
PI on 1 active trial
DD
David DM MALLET, Director
Amiens
Specialist

Rare Disease Specialist

JF
Jonathan Fryer
SAN DIEGO, CA
Specialist
PI on 1 active trial
PW
Paul Wales
CINCINNATI, OH
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

CHU de Caen

📍 Caen

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Financial Resources

2 resources

XIFAXAN

Salix

Irritable Bowel Syndrome

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

Gattex

Takeda

Short Bowel Syndrome

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to Short bowel syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Short bowel syndromeForum →

No community posts yet. Be the first to share your experience with Short bowel syndrome.

Start the conversation →

Latest news about Short bowel syndrome

Disease timeline:

New recruiting trial: A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: A Study of Teduglutide in Japanese People With Short Bowel Syndrome

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: Elemental 028 Extra Case Studies

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

A new clinical trial is recruiting patients for Short bowel syndrome

New recruiting trial: A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome

A new clinical trial is recruiting patients for Short bowel syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Short bowel syndrome

Are there clinical trials for Short bowel syndrome?

Yes — 20 recruiting clinical trials are currently listed for Short bowel syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Short bowel syndrome?

25 specialists and care centers treating Short bowel syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Short bowel syndrome?

2 patient support programs are currently tracked on UniteRare for Short bowel syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.